Oncology · Phase III

Top sponsors

• AstraZeneca 75 programs
• Chinese Academy of 70 programs
• HOFFMANN-LA ROCHE 68 programs
• MSD Merck Sharp 56 programs
• First People's Hospital 53 programs
• Ningbo Cancer Hospital 44 programs
• United Therapeutics Europe 43 programs
• Anaxis Pharma 37 programs
• AstraZeneca 37 programs
• Novartis India 32 programs
• George Institute for 29 programs
• Takeda 28 programs

1. PH-L19TNFDOX2-03/16

   Philogen S.p.A.

   Unresectable or metastatic soft tissue sarcoma

   phase 3 · small molecule · active

   1 trial →

2. PIPAC_VEROne

   Verona Pharma Ireland Limited

   Gastric adenocarcinoma with peritoneal metastases

   phase 3 · small molecule · active

   1 trial →

3. PM1183-C-008-21

   Lacuna Pharma Pty Ltd

   Small Cell Lung Cancer (SCLC)

   phase 3 · small molecule · active

   1 trial →

4. PR-30-5017-C

   TESARO Bio Netherlands B.V.

   Homologous recombination deficiency advanced ovarian cancer

   phase 3 · small molecule · active

   1 trial →

5. PRISM-1

   Arcus Biosciences

   Pancreatic cancer, Metastatic Pancreatic ductal adenocarcinoma (mPDAC), Pancreatic ductal adenocarcinoma (PDAC)

   phase 3 · small molecule · active

   1 trial →

6. PRODIGE 118-PEHRICCA

   CERO THERAPEUTICS HOLDINGS, INC.

   Hihg risk of cholangiocarcinoma intra hépatic resectable

   phase 3 · small molecule · active

   1 trial →

7. PRODIGE 49 -OSCAR

   CERO THERAPEUTICS HOLDINGS, INC.

   colon cancer and rectal with liver metastasis

   phase 3 · small molecule · active

   1 trial →

8. PRODIGE 51 - GASTFOX

   CERO THERAPEUTICS HOLDINGS, INC.

   Locally advanced or metastatic oesogastric adenocarcinoma

   phase 3 · small molecule · active

   1 trial →

9. PRODIGE85-KANALRAD

   CERO THERAPEUTICS HOLDINGS, INC.

   locally advanced anal squamous cell carcinoma

   phase 3 · small molecule · active

   1 trial →

10. PROICM 2018-01 NEX

    The George Institute

    Metastatic colorectal cancer

    phase 3 · small molecule · active

    1 trial →

11. PROICM 2021-01 GRE

    The George Institute

    Rectum cancer

    phase 3 · small molecule · active

    1 trial →

12. PROpel D081SC00001

    AstraZeneca AB

    Metastatic castration-resistant prostate cancer

    phase 3 · small molecule · active

    1 trial →

13. PSMA-11 kit for Ga-68 labelling

    Bial Portela & Companhia S.A.

    Intermediate and high-risk prostate cancer

    phase 3 · small molecule · active

    1 trial →

14. PV-10 (10% rose bengal disodium)

    PROVECTUS BIOPHARMACEUTICALS, INC.

    Cutaneous Melanoma

    phase 3 · small molecule · terminated

    1 trial →

15. Paclitaxel

    The First People's Hospital of Lianyungang

    Esophageal Cancer

    phase 3 · small molecule · active

    1 trial →

16. Paclitaxel

    Cellectar Biosciences

    Non Small Cell Lung Cancer

    phase 3 · small molecule · completed

    1 trial →

17. Paclitaxel dosing according to SmPC

    BRIGHT MINDS BIOSCIENCES INC.

    Carcinoma, Non-Small-Cell Lung

    phase 3 · small molecule · completed

    1 trial →

18. Paclitaxel or docetaxel + Cisplatin or carboplatin

    The First People's Hospital of Lianyungang

    Uterine Cervical Neoplasms

    phase 3 · small molecule · active

    1 trial →

19. Paclitaxel, Cisplatin Plus 5-FU (TCF)

    The First People's Hospital of Lianyungang

    Esophageal Cancer Stage IIB

    phase 3 · other · active

    1 trial →

20. Palazestrant

    Olema Pharmaceuticals

    Breast Cancer

    phase 3 · small molecule · active

    3 trials →

21. Palbociclib

    Pfizer

    Metastatic Breast Cancer

    phase 3 · small molecule · completed

    1 trial →

22. Palliative Chemotherapy

    Sun Yat-sen University

    Colorectal Neoplasms Malignant

    phase 3 · small molecule · active

    1 trial →

23. Pamiparib capsule

    BeiGene

    Ovarian Cancer

    phase 3 · small molecule · active

    1 trial →

24. Pamiparib capsule

    BEONE MEDICINES AUS PTY LTD

    Ovarian Cancer

    phase 3 · small molecule · active

    1 trial →

25. Panitumumab

    Amgen

    Metastatic Colorectal Cancer

    phase 3 · small molecule · completed

    1 trial →

26. Panitumumab-3001

    Takeda

    Colorectal Cancer

    phase 3 · small molecule · completed

    1 trial →

27. Pegylated Interferon Alfa-2a

    Hoffmann-La Roche

    Chronic Myelogenous Leukemia

    phase 3 · small molecule · completed

    1 trial →

28. Pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Carcinoma, Renal Cell

    phase 3 · mab · active

    1 trial →

29. Pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Cervical Cancer

    phase 3 · mab · completed

    1 trial →

30. Pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Endometrial Neoplasms

    phase 3 · mab · active

    1 trial →

31. Pembrolizumab

    Incyte

    Renal Cell Carcinoma (RCC)

    phase 3 · small molecule · completed

    1 trial →

32. Pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Renal Cell Carcinoma

    phase 3 · mab · completed

    1 trial →

33. Pembrolizumab

    Eisai Co.,

    Endometrial Neoplasms

    phase 3 · small molecule · completed

    1 trial →

34. Pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Triple Negative Breast Neoplasms

    phase 3 · mab · completed

    1 trial →

35. Pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Urinary Bladder Neoplasms

    phase 3 · small molecule · active

    1 trial →

36. Pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Ovarian Cancer

    phase 3 · mab · completed

    1 trial →

37. Pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Solid Tumors

    phase 3 · small molecule · active

    1 trial →

38. Pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Gastric Neoplasms

    phase 3 · mab · completed

    1 trial →

39. Pembrolizumab

    The First People's Hospital of Lianyungang

    Esophageal Squamous Cell Carcinoma

    phase 3 · mab · active

    1 trial →

40. Pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Metastatic Esophageal Squamous Cell Carcinoma

    phase 3 · mab · active

    1 trial →

41. Pembrolizumab (K)

    Merck KGaA, Darmstadt, Germany

    Breast Cancer

    phase 3 · mab · active

    1 trial →

42. Pembrolizumab 25 MG/ML [Keytruda]

    United Therapeutics Europe Ltd

    Lung Cancer, Nonsmall Cell

    phase 3 · small molecule · active

    1 trial →

43. Pembrolizumab/Vibostolimab

    Merck KGaA, Darmstadt, Germany

    Lung Neoplasms

    phase 3 · mab · completed

    1 trial →

44. Pemetrexed

    Regeneron UK Limited

    Carcinoma，Non-Small-Cell Lung

    phase 3 · small molecule · completed

    1 trial →

45. Pemetrexed

    Boehringer Ingelheim

    Carcinoma, Non-Small-Cell Lung

    phase 3 · small molecule · completed

    1 trial →

46. Pemetrexed

    Eli Lilly and Company

    Non-Small Cell Lung Cancer

    phase 3 · small molecule · completed

    2 trials →

47. Pemigatinib

    Incyte

    Unresectable Cholangiocarcinoma

    phase 3 · small molecule · terminated

    1 trial →

48. Placebo

    Sanofi Pasteur

    Colorectal Neoplasms

    phase 3 · small molecule · completed

    1 trial →

Frequently asked questions